World News
Politics
Stock
Investing
Editor’s Pick

RAD Doses 1st Patient in Therapeutic Trial of 177Lu-RAD202

by admin June 4, 2025

June 4, 2025

Radiopharm Theranostics (RAD:AU) has announced RAD Doses 1st Patient in Therapeutic Trial of 177Lu-RAD202

Download the PDF here.

This post appeared first on investingnews.com

previous post

The Best Five Sectors, #21

next post

Adam Rozencwajg: Gold Stock Gains, Silver and Uranium Prices — Plus PGMs Bull Case

Related Posts

Germany, Italy Face Pressure to Repatriate US$245 Billion...

June 25, 2025

Top 10 Copper-producing Companies

June 25, 2025

Preparations for Maiden Drill Program at Oasis

June 25, 2025

Rio Tinto and Hancock Pledge US$1.6 Billion to...

June 25, 2025

Lode Gold Engages Strategic Advisors to Advance Development...

June 25, 2025

Change of Management Role

June 24, 2025

Stay updated with the latest news, exclusive offers, and special promotions. Sign up now and be the first to know! As a member, you'll receive curated content, insider tips, and invitations to exclusive events. Don't miss out on being part of something special.

Your name
Your email

By opting in you agree to receive emails from us and our affiliates. Your information is secure and your privacy is protected.

Recent Posts

How Fanatics is teaching business acumen to pro athletes

June 25, 2025
Offense vs. Defense: How Geopolitical Tensions Shape Market Trends

June 25, 2025
How to Use Fibonacci Retracements to Spot Key Levels

June 25, 2025
Shifting Tides in the Stock Market: A New Era for Bulls?

June 25, 2025
Dem senator plows ahead with war powers resolution despite ceasefire

June 25, 2025

About us
Contact us
Privacy Policy
Terms & Conditions

Copyright © 2025 timeandsalesreporter.com | All Rights Reserved

World News
Politics
Stock
Investing
Editor’s Pick

Read alsox

The Case for Repealing the Corporate SALT Deduction

March 13, 2025

A US Sovereign Wealth Fund and Tariffs

March 11, 2025

Freedom to Offend Under Threat Across Europe

February 6, 2025